Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Terminated
1(11%)

Phase Distribution

Ph not_applicable
6
67%
Ph phase_1
1
11%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
N/ANon-phased studies
6(85.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(4)
Terminated(2)
Other(2)

Detailed Status

Completed4
unknown2
Not yet recruiting1
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
80.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (14.3%)
N/A6 (85.7%)

Trials by Status

not_yet_recruiting111%
withdrawn111%
unknown222%
completed444%
terminated111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
9